Outcomes of Transcatheter Aortic Valve Replacement in Patients With Severely Reduced Left Ventricular Systolic Function in the Low Systolic Function and Transcatheter Aortic Valve Implantation (LOSTAVI) International Registry.
暂无分享,去创建一个
I. Porto | F. Musumeci | F. Maisano | M. Cimmino | M. Albanese | G. Galasso | M. Vercellino | G. Biondi‐Zoccai | F. Bedogni | M. Barbanti | L. Testa | O. De Backer | L. Søndergaard | A. Schaefer | A. Giordano | O. Bhadra | C. Musto | M. Pepe | A. Iadanza | F. Bruno | A. Berni | V. Cesario | D. Schiavi | M. Fineschi | F. Giacobbe | N. Corcione | Salvatore Giordano | G. Costa | F. D’Ascenzo | A. Cammardella | A. Morello | S. Zecchino | Sofia Sammartino | Marie Dalsgaard | Javier Gómez Herrero | Edoardo Zancarano | O. de Backer
[1] C. Kliger,et al. Comparison of Periprocedural and Intermediate-Term Outcomes of TAVI in Patients with Ejection Fraction ≤ 20% vs. Patients with 20% < EF ≤ 40% , 2023, Journal of clinical medicine.
[2] M. Velez. Advances in contemporary medical management to treat patients with heart failure , 2023, Current opinion in cardiology.
[3] P. Meraj,et al. Transcatheter heart valve selection in patients with low ejection fraction and aortic stenosis , 2022, Journal of cardiac surgery.
[4] M. Cimmino,et al. Transcatheter aortic valve implantation with Allegra: procedural and mid-term outcomes according to experience phase in a high-volume center. , 2022, Minerva cardiology and angiology.
[5] T. Shimura,et al. Transcatheter aortic valve implantation and frailty , 2022, Cardiovascular Intervention and Therapeutics.
[6] P. Blanke,et al. TAVR for All? The Surgical Perspective , 2022, Journal of cardiovascular development and disease.
[7] M. Niemelä,et al. Percutaneous vs surgical axillary access for transcatheter aortic valve implantation: the TAXI registry. , 2022, Panminerva medica.
[8] M. Cimmino,et al. Transcatheter aortic valve implantation with the novel‐generation Navitor device: Procedural and early outcomes , 2022, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.
[9] Nader Alasousi,et al. Clinical outcomes of transcatheter aortic valve replacement stratified by left ventricular ejection fraction: A single centre pilot study , 2022, Annals of medicine and surgery.
[10] L. Menicanti,et al. Durability of surgical and transcatheter aortic bioprostheses. A review of the literature. , 2022, Cardiovascular revascularization medicine : including molecular interventions.
[11] T. Puehler,et al. Left ventricular ejection fraction is associated with intraoperative circulatory collapse during transcatheter aortic valve implantation , 2021, Annals of translational medicine.
[12] L. Davidson,et al. Transcatheter Treatment of Valvular Heart Disease: A Review. , 2021, JAMA.
[13] Seung‐Jung Park,et al. Incidence, Predictors, and Prognostic Impact of Immediate Improvement in Left Ventricular Systolic Function After Transcatheter Aortic Valve Implantation. , 2021, The American journal of cardiology.
[14] T. Nazif,et al. Percutaneous mechanical circulatory support from the collaborative multicenter Mechanical Unusual Support in TAVI (MUST) Registry , 2021, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.
[15] J. Leipsic,et al. Valve Academic Research Consortium 3: updated endpoint definitions for aortic valve clinical research. , 2021, European heart journal.
[16] C. Trani,et al. Baseline, procedural and outcome features of patients undergoing transcatheter aortic valve implantation according to different body mass index categories. , 2021, Minerva medica.
[17] S. Bertog,et al. Impella Placement Across Transcatheter Aortic Valves: A Potential for Device-Device Interaction. , 2020, JACC. Cardiovascular interventions.
[18] S. de Servi,et al. Comparative one-month safety and effectiveness of five leading new-generation devices for transcatheter aortic valve implantation , 2019, Scientific Reports.
[19] M. Totzeck,et al. Impact of baseline left ventricular ejection fraction on outcome after transfemoral transcatheter aortic valve implantation in patients with and without low‐gradient aortic stenosis , 2018, Echocardiography.
[20] C. Indolfi,et al. Patterns and trends of transcatheter aortic valve implantation in Italy: insights from RISPEVA , 2017, Journal of cardiovascular medicine.
[21] K. Kuck,et al. Comparison of outcomes of patients with left ventricular ejection fractions ≤30% versus ≥30% having transcatheter aortic valve implantation (from the German Transcatheter Aortic Valve Interventions Registry). , 2015, The American journal of cardiology.
[22] Yong Peng,et al. Efficacy of transcatheter aortic valve implantation in patients with aortic stenosis and reduced LVEF , 2015, Herz.
[23] R. Cartier,et al. Impact of coronary artery disease on left ventricular ejection fraction recovery following transcatheter aortic valve implantation , 2015, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.
[24] A. Cribier. The Odyssey of TAVR from concept to clinical reality. , 2014, Texas Heart Institute journal.
[25] P. Wenaweser,et al. Transcatheter aortic valve implantation: patient selection. , 2013, Minerva cardioangiologica.
[26] N. Marchionni,et al. Role of Frailty on Risk Stratification in Cardiac Surgery and Procedures. , 2020, Advances in experimental medicine and biology.
[27] T. Durmaz,et al. Impact of transcatheter aortic valve implantation in patients with reduced ejection fraction. , 2015, Cardiology journal.